It was previously established that cross-talk between TRAIL signaling and mitochondrial-mediated apoptosis exists [35] and that upon TRAIL treatment, mitochondrial potential decreases in cancer cells, correlating with selective TRAIL-induced apoptosis in cancer cells [36]. The gene discussed is TNFSF10; the disease is cancer.